https://www.openpr.com/news/1582085/New-Study-On-Glomerulonephritis-Treatment-Market-2019-2025-Anthera-Pharmaceuticals-Biogen-Bristol-Myers-Squibb-Cellmid-ChemoCentryx-Complexa-Dimerix-Bioscience-GlaxoSmithKline-Merck-Omeros-Pfizer.html
In case you missed it.